Europium (III) chelate nanoparticle-based lateral flow immunoassay strips for rapid and quantitative detection of cystatin C in serum

J Chromatogr B Analyt Technol Biomed Life Sci. 2022 Apr 1:1194:123133. doi: 10.1016/j.jchromb.2022.123133. Epub 2022 Jan 20.

Abstract

The concentration of Cys C in the patient's serum can reflect the level of glomerular filtration rate and indicate the occurrence of renal failure. The establishment of a simple and rapid analytical method to quantitatively monitor the concentration of Cys C in serum could help timely detection of renal failure. In this study, we have developed an Eu (III) chelate nanoparticles based lateral flow immunoassay to fulfill real-time monitoring of Cys C concentration in serum within 15 min. This method was performed as a sandwich immunoassay with a wide detection range (0.05-10 μg/mL) and a low limit of detection (24.54 ng/mL). The intra and inter-assay coefficients of variation were 8.31-8.61% and 8.92-9.95%, respectively. Furthermore, the application of this method was evaluated by comparing the determined results with those obtained by chemiluminescence immunoassay, exhibiting a satisfactory correlation (R2 = 0.9830). The developed LFIA method with satisfactory analytical performance has great potential for real-time monitoring of renal failure and self-detection for the high-risk population.

Keywords: Cystatin C; Europium-chelate nanoparticles; Glomerular filtration rate; Lateral flow immunoassay; Renal failure.

Publication types

  • Evaluation Study

MeSH terms

  • Cystatin C / blood*
  • Europium / chemistry*
  • Humans
  • Immunoassay / instrumentation
  • Immunoassay / methods*
  • Metal Nanoparticles / chemistry*
  • Renal Insufficiency / blood*
  • Renal Insufficiency / diagnosis

Substances

  • Cystatin C
  • Europium